arrow
C

Christopher Colombo

madigan army medical center
H指数:19
被引数:1,238

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

An Egocentric Life-Saving Interventional Procedure Dataset of Actions, Medical Questions, Maneuvers and Tools

一个以自我为中心的救命介入程序数据集,包含动作、医学问题、操作和工具

2025-12-180
OAAI
SARS-CoV-2 variant replacement constrains vaccine-specific viral diversification
2024-09-020
OAAI
Precision Symptom Phenotyping Identifies Early Clinical and Proteomic Predictors of Distinct COVID-19 Sequelae

精确的症状表型可确定不同新型冠状病毒肺炎后遗症的早期临床和蛋白质组学预测指标

2024-06-252
OAAI
Decreased Self-reported Physical Fitness Following SARS-CoV-2 Infection and the Impact of Vaccine Boosters in a Cohort Study

队列研究中SARS-CoV-2感染后自我报告的身体健康下降和疫苗增强剂的影响

2023-11-171
OAAI
Evaluating Demographic Representation in Clinical Trials: Use of the Adaptive Coronavirus Disease 2019 Treatment Trial (ACTT) as a Test Case
2023-05-271
OA
Distinct blood inflammatory biomarker clusters stratify host phenotypes during the middle phase of COVID-19
2022-12-286
OAAI
Temporal Improvements in COVID-19 Outcomes for Hospitalized Adults: A Post Hoc Observational Study of Remdesivir Group Participants in the Adaptive COVID-19 Treatment Trial
2022-12-014
OA
Understanding Hybrid Immunity: Comparison and Predictors of Humoral Immune Responses to Severe Acute Respiratory Syndrome Coronavirus 2 Infection (SARS-CoV-2) and Coronavirus Disease 2019 (COVID-19) Vaccines

了解杂交免疫: 对新型冠状病毒感染 (SARS-CoV-2) 和冠状病毒病2019 (新型冠状病毒肺炎) 疫苗的体液免疫反应的比较和预测

2022-07-0539
OA
An Analysis of SARS-CoV-2 Vaccine Reactogenicity: Variation by Type, Dose, and History, Severity, and Recency of Prior SARS-CoV-2 Infection

SARS-CoV-2疫苗反应原性分析: 先前SARS-CoV-2感染的类型,剂量,病史,严重程度和新近程度的变化

2022-06-282
OAAI
COVID-19 Patient-Reported Symptoms Using FLU-PRO Plus in a Cohort Study: Associations With Infecting Genotype, Vaccine History, and Return to Health
2022-06-075
OAAI
SARS-CoV-2 BA.1 variant is neutralized by vaccine booster-elicited serum but evades most convalescent serum and therapeutic antibodies
2022-05-1871
OAAI
Anatomical Site, Viral Ribonucleic Acid Abundance, and Time of Sampling Correlate With Molecular Detection of Severe Acute Respiratory Syndrome Coronavirus 2 During Infection
2021-12-081
OAAI
COVID-19 Outcomes Among US Military Health System Beneficiaries Include Complications Across Multiple Organ Systems and Substantial Functional Impairment
2021-11-1019
OAAI
Durability of SARS-CoV-2-Specific T-Cell Responses at 12 Months Postinfection
2021-10-2129
OA
Performance of the inFLUenza Patient-Reported Outcome Plus (FLU-PRO Plus) Instrument in Patients With Coronavirus Disease 2019
2021-10-0815
OA
Clinical, Immunological, and Virological SARS-CoV-2 Phenotypes in Obese and Nonobese Military Health System Beneficiaries
2021-07-3113
OAAI